Fuzzy Wale Compression Stockinet to Promote Healing Following Transtibial Amputation for Peripheral Arterial Disease

Overview

About this study

The objective of this study is to determine if using Fuzzy Wale compression stockinett can assist in reducing the healing time and decrease costs in trastibial amputation patients as compared to standard of care treatment compression stocking.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • ≥ 18 years.
  • Male and female.
  • Transtibial amputation expected.
  • Peripheral arterial disease, Ankle Brachial Index (ABI) and Transcutaneous partial pressure of oxygen (TCP02, if performed).
  • Diabetes.
  • Tobacco use at any time in past or current use (pack years).
  • On dialysis (hemodialysis and peritoneal).
  • Prior contralateral leg amputation.
  • Ability of subject to give appropriate consent or have an appropriate representative available to do so.

Exclusion Criteria:

  • TcPO2 < 20 (Transcutaneous Cutaneous Partial pressure of oxygen).
  • Known allergies to any of the components of the compression.
  • Terminal illness or current cancer therapy with chemotherapy.
  • Inability to undergo ongoing care in Rochester.
  • Lack of cognitive ability to follow instructions or monitor residual limb.
  • Vulnerable study population.
  • Pregnancy.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 11/2/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Melin, M.D.

Contact us for the latest status

Contact information:

Charlene Blanchard CCRP

(507) 538-8152

Blanchard.Charlene@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20571743

Mayo Clinic Footer